融合筋膜联合植入物即刻乳房重建的可行性研究

目的:探讨融合筋膜法进行植入物即刻乳房重建的肿瘤学及外科学安全性。方法:回顾性分析2014—2017年天津医科大学肿瘤医院343例植入物乳房即刻重建患者的临床资料,比较融合筋膜与其他方法乳房重建患者的5年无局部区域复发生存率、5年无病生存率和5年总生存率,分析不同植入物患者组间发生植入物取出的并发症发生率。结果:343例乳房重建患者中,融合筋膜组(筋膜组)95例,非筋膜组248例(牛心包补片组25例,肌瓣组223例)。中位随访49个月,筋膜组与非筋膜组患者的5年无局部区域复发生存率(分别为90.1%和94.9%)、5年无病生存率(分别为89.2%和87.6%)和5年总生存率(分别为95.2%和...

Full description

Saved in:
Bibliographic Details
Published in中华肿瘤杂志 Vol. 45; no. 6; pp. 514 - 518
Main Authors 陈祖锦, 陈翱翔, 张斌, 王欣, 曹旭晨
Format Journal Article
LanguageChinese
Published 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 天津市恶性肿瘤临床医学研究中心 乳腺癌防治教育部重点实验室 天津医科大学肿瘤医院乳腺肿瘤一科,天津 300060 01.06.2023
Subjects
Online AccessGet full text
ISSN0253-3766
DOI10.3760/cma.j.cn112152-20220419-00270

Cover

Abstract 目的:探讨融合筋膜法进行植入物即刻乳房重建的肿瘤学及外科学安全性。方法:回顾性分析2014—2017年天津医科大学肿瘤医院343例植入物乳房即刻重建患者的临床资料,比较融合筋膜与其他方法乳房重建患者的5年无局部区域复发生存率、5年无病生存率和5年总生存率,分析不同植入物患者组间发生植入物取出的并发症发生率。结果:343例乳房重建患者中,融合筋膜组(筋膜组)95例,非筋膜组248例(牛心包补片组25例,肌瓣组223例)。中位随访49个月,筋膜组与非筋膜组患者的5年无局部区域复发生存率(分别为90.1%和94.9%)、5年无病生存率(分别为89.2%和87.6%)和5年总生存率(分别为95.2%和95.1%)差异均无统计学意义(均 P>0.05)。补片组植入物取出的并发症发生率为24.0%(6/25),筋膜组与肌瓣组分别为2.1%(2/95)和2.2%(5/223)。 结论:融合筋膜联合植入物即刻乳房重建是安全可行的,较肌肉瓣损伤小,与补片比较更经济且并发症少。
AbstractList 目的:探讨融合筋膜法进行植入物即刻乳房重建的肿瘤学及外科学安全性。方法:回顾性分析2014—2017年天津医科大学肿瘤医院343例植入物乳房即刻重建患者的临床资料,比较融合筋膜与其他方法乳房重建患者的5年无局部区域复发生存率、5年无病生存率和5年总生存率,分析不同植入物患者组间发生植入物取出的并发症发生率。结果:343例乳房重建患者中,融合筋膜组(筋膜组)95例,非筋膜组248例(牛心包补片组25例,肌瓣组223例)。中位随访49个月,筋膜组与非筋膜组患者的5年无局部区域复发生存率(分别为90.1%和94.9%)、5年无病生存率(分别为89.2%和87.6%)和5年总生存率(分别为95.2%和95.1%)差异均无统计学意义(均 P>0.05)。补片组植入物取出的并发症发生率为24.0%(6/25),筋膜组与肌瓣组分别为2.1%(2/95)和2.2%(5/223)。 结论:融合筋膜联合植入物即刻乳房重建是安全可行的,较肌肉瓣损伤小,与补片比较更经济且并发症少。
Abstract_FL Objective:To investigate the oncologic and surgical safety of the fused fascia method for immediate breast reconstruction with implants.Methods:The clinical data of 343 patients with immediate breast reconstruction with implants in Tianjin Medical University Cancer Hospital from 2014-2017 were retrospectively analyzed to compare the 5-year local recurrence-free survival, 5-year disease-free survival and 5-year overall survival of patients with breast reconstruction by fusion fascia and other methods, and to analyze the complication incidences of implant removal between different implant groups.Results:Of the 343 patients with breast reconstruction, 95 were in the fused fascia group (fascia group) and 248 were in the non-fascia group (25 in the bovine pericardial patch group and 223 in the muscle flap group). At a median follow-up of 49 months, the differences in 5-year local recurrence-free survival (90.1% and 94.9%, respectively), 5-year disease-free survival (89.2% and 87.6%, respectively), and 5-year overall survival (95.2% and 95.1%, respectively) between patients in the fascial and non-fascial groups were not statistically significant ( P>0.05). The complication incidence of implant removal was 24.0% (6/25) in the patch group and 2.1% (2/95) and 2.2% (5/223) in the fascia and muscle flap groups, respectively. Conclusion:Immediate breast reconstruction with fused fascial combined with implant is safe and feasible, less invasive than muscle flaps, more economical and with fewer complications than patches.
Author 陈祖锦
曹旭晨
王欣
张斌
陈翱翔
AuthorAffiliation 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 天津市恶性肿瘤临床医学研究中心 乳腺癌防治教育部重点实验室 天津医科大学肿瘤医院乳腺肿瘤一科,天津 300060
AuthorAffiliation_xml – name: 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 天津市恶性肿瘤临床医学研究中心 乳腺癌防治教育部重点实验室 天津医科大学肿瘤医院乳腺肿瘤一科,天津 300060
Author_FL Chen Aoxiang
Cao Xuchen
Wang Xin
Chen Zujin
Zhang Bin
Author_FL_xml – sequence: 1
  fullname: Chen Zujin
– sequence: 2
  fullname: Chen Aoxiang
– sequence: 3
  fullname: Zhang Bin
– sequence: 4
  fullname: Wang Xin
– sequence: 5
  fullname: Cao Xuchen
Author_xml – sequence: 1
  fullname: 陈祖锦
– sequence: 2
  fullname: 陈翱翔
– sequence: 3
  fullname: 张斌
– sequence: 4
  fullname: 王欣
– sequence: 5
  fullname: 曹旭晨
BookMark eNotjztLA0EcxLeIYIz5GCnv_O_zdiuR4AsCNlqHu_VWDXEDHiKkUvAR0UOLVCKioEgKsQgImsIv496d38JDnWamGObHzKCK7dkYoQYGnwYC5vRu6Hd8bTEmmBOPACHAsPIASAAVVAXCqVc2xTSqJ8lOBFzygCkcVNF8cZe660H-clGc3hZHwzJnj6k7ecrPRy4du8Hk632cDT6_z1I3-chvjt3Va_FwmR0-5_fDfPQ2i6ZM2E3i-r_X0MbS4npzxWutLa82F1peggGkJ5g2OsI6AKZV9CspBRWgQBrGBGVKhrHinPJQ8YBSrYxkOgJjhNCbnNZQ42_3ILQmtFvtTm9_z5bEdn-73y0fUxAliP4Az9NkeQ
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.cn112152-20220419-00270
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Feasibility study of immediate breast reconstruction with fusion fascia combined with implants
EndPage 518
ExternalDocumentID zhzl202306008
GroupedDBID ---
-05
123
2B.
4A8
92F
92I
93N
ABDBF
ABJNI
ACGFS
ACUHS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CW9
EOJEC
OBODZ
PSX
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1008-64cfcb1c704c9bbbbbb886360908f4463498ae95535a95733c9f84cb0ff66cd53
ISSN 0253-3766
IngestDate Thu May 29 04:07:58 EDT 2025
IsPeerReviewed false
IsScholarly true
Issue 6
Keywords 乳腺肿瘤
融合筋膜
乳房重建
植入物
Prosthesis
Breast reconstruction
Breast neoplasms
Fused fascia
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1008-64cfcb1c704c9bbbbbb886360908f4463498ae95535a95733c9f84cb0ff66cd53
PageCount 5
ParticipantIDs wanfang_journals_zhzl202306008
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationTitle 中华肿瘤杂志
PublicationTitle_FL Chinese Journal of Oncology
PublicationYear 2023
Publisher 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 天津市恶性肿瘤临床医学研究中心 乳腺癌防治教育部重点实验室 天津医科大学肿瘤医院乳腺肿瘤一科,天津 300060
Publisher_xml – name: 国家肿瘤临床医学研究中心 天津市肿瘤防治重点实验室 天津市恶性肿瘤临床医学研究中心 乳腺癌防治教育部重点实验室 天津医科大学肿瘤医院乳腺肿瘤一科,天津 300060
SSID ssib058574917
ssib051368316
ssib007279245
ssib000995398
ssj0042033
ssib006576341
ssib001103529
Score 2.3736503
Snippet ...
SourceID wanfang
SourceType Aggregation Database
StartPage 514
Title 融合筋膜联合植入物即刻乳房重建的可行性研究
URI https://d.wanfangdata.com.cn/periodical/zhzl202306008
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3NaxNBFF9KC-JFFBU_Sw_OMXU_ZmZnTjKbbCiCnlrorexH1iIawbaXnBT8qGjQQ08ioqBID-KhIGoP_jOmif-F771Mk20TtYoYQpjMvjfvvd97zL5ZZt46zoUgkXmaJBqWJbms8EbiVXSW55UCbu9cFX5R-Hh2-MpVObfALy-KxYmpT6VdS2ur6WzWGnuu5G-8Cn3gVzwl-weeHQwKHdAG_8IveBh-D-RjFiumY6ZqLBZMu0wpFofM1JiK8JKSTFep4THNSzSSGW65lGBGIJfSzGjqqbEooIZiEYzDWaSpR1JPncWaqdCyA0FkkF0bpkiEqjNTR6HGY6pKXC4zISnmkhohCopkOS0mKQo17yugYlLbJ3EwuEKFYShdw06UW2d6cAdFjbTetR6slNTDmZFjSYA58mxD8yEJDFtFJVEQqF0dXglRIwQVkAOSoPysxA-Ge7oouglowIWMMTGYOs4YMjgiyABBZcjyKiEuEAgjRyHbAxOMpsArAeILX-Ti5EKJw6JTBRIjXqPSNTYin4h9EjpwakjE2ioP4QWXjCFfUg-yH0SoxLBDnQcR8B9AGASrwsi2oalJ-VGTwc0Cr1rFfAIhYEb9SzSsOSEioL1dmrBk4CgsAy4KWuOPs-snYKIaA1l1DGir6j7FrM4BlUoqZQO-CDAbkOXUpV-J1U7R5TxE9E9m25RW9FOc_dkS7oeDKS67mcxen82aHhaa8WGC9X2X49FG1--_02dfQfrWcuuGT48uqMrClB-GuEFmykS1qF5aumlRLi0KywxY6w2XTlJAZlNaioVYyXS4w0F4gVTBcOkqlAg5PVrqZ9ncdwPaPbQLyyGHWZMu_tIgOpzZLJLmtdI6Yv6oc8Q-AJgx_dn8mDPRWj7uXOq9bHeerXffP-49eNG7uwHtnTftzv233UebnfZWZ3372-etnfWv3x-2O9tfus_vdZ5-6L1-snPnXffVRnfz4wlnoR7PV-cq9tU2lRWsplaRPCuy1MtCl2c6pY9SWLpRu6rgHJDRKmloIQKRaCxZm-lC8Sx1i0LKLBfBSWeyeavZOOXM5DnWHG2EWa5cLos0DXXiZgn8SzyVZPK0M20NXrK3rpWlPS488zuCs87h4WR6zplcvb3WOA9LsdV02nr9B6JqDF4
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%9E%8D%E5%90%88%E7%AD%8B%E8%86%9C%E8%81%94%E5%90%88%E6%A4%8D%E5%85%A5%E7%89%A9%E5%8D%B3%E5%88%BB%E4%B9%B3%E6%88%BF%E9%87%8D%E5%BB%BA%E7%9A%84%E5%8F%AF%E8%A1%8C%E6%80%A7%E7%A0%94%E7%A9%B6&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%82%BF%E7%98%A4%E6%9D%82%E5%BF%97&rft.au=%E9%99%88%E7%A5%96%E9%94%A6&rft.au=%E9%99%88%E7%BF%B1%E7%BF%94&rft.au=%E5%BC%A0%E6%96%8C&rft.au=%E7%8E%8B%E6%AC%A3&rft.date=2023-06-01&rft.pub=%E5%9B%BD%E5%AE%B6%E8%82%BF%E7%98%A4%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%E3%80%80%E5%A4%A9%E6%B4%A5%E5%B8%82%E8%82%BF%E7%98%A4%E9%98%B2%E6%B2%BB%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%E3%80%80%E5%A4%A9%E6%B4%A5%E5%B8%82%E6%81%B6%E6%80%A7%E8%82%BF%E7%98%A4%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%E3%80%80%E4%B9%B3%E8%85%BA%E7%99%8C%E9%98%B2%E6%B2%BB%E6%95%99%E8%82%B2%E9%83%A8%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%E3%80%80%E5%A4%A9%E6%B4%A5%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2%E4%B9%B3%E8%85%BA%E8%82%BF%E7%98%A4%E4%B8%80%E7%A7%91%EF%BC%8C%E5%A4%A9%E6%B4%A5%E3%80%80300060&rft.issn=0253-3766&rft.volume=45&rft.issue=6&rft.spage=514&rft.epage=518&rft_id=info:doi/10.3760%2Fcma.j.cn112152-20220419-00270&rft.externalDocID=zhzl202306008
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhzl%2Fzhzl.jpg